Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-12-23 Purchase |
2024-12-26 08:50 am |
IO Biotech Inc. | IOBT | Ahmad Qasim Iftikhar Chief Medical Officer |
31,350 | $0.847 | $26,553 | 31,350 (Direct) |
View |
| 2024-12-23 Purchase |
2024-12-23 6:56 pm |
IO Biotech Inc. | IOBT | Zocca Mai-Britt Chief Executive Officer |
12,500 | $0.8096 | $10,120 | 76,471 (Indirect Direct) |
View |
| 2024-12-23 Purchase |
2024-12-23 6:53 pm |
IO Biotech Inc. | IOBT | Sullivan Amy Chief Financial Officer |
10,250 | $0.8276 | $8,483 | 84,632 (Direct) |
View |
| 2024-12-23 Purchase |
2024-12-23 6:52 pm |
IO Biotech Inc. | IOBT | Smith Devin Whittemore General Counsel |
12,000 | $0.81 | $9,720 | 16,938 (Direct) |
View |
| 2024-07-25 Sale |
2024-07-26 9:22 pm |
IO Biotech Inc. | IOBT | Novo Holdings A/S 10% Owner |
75,000 | $1.3217 | $99,125 | 4,354,449 (Direct) |
View |
| 2024-05-10 Sale |
2024-05-14 9:13 pm |
IO Biotech Inc. | IOBT | Novo Holdings A/S 10% Owner |
658,809 | $1.2181 | $802,495 | 4,429,449 (Direct) |
View |
| 2024-02-09 Sale |
2024-02-13 9:31 pm |
IO Biotech Inc. | IOBT | Novo Holdings A/S 10% Owner |
658,809 | $1.5003 | $988,411 | 5,088,258 (Direct) |
View |
| 2023-11-21 Purchase |
2023-11-24 5:37 pm |
IO Biotech Inc. | IOBT | Burkavage Brian Chief Accounting Officer |
10,000 | $1.0125 | $10,125 | 11,500 (Direct) |
View |
| 2023-08-09 Purchase |
2023-08-11 4:31 pm |
IO Biotech Inc. | IOBT | Novo Holdings A/S 10% Owner |
2,469,135 | $2.025 | $4,999,998 | 8,176,602 (Direct) |
View |
| 2023-08-09 Purchase |
2023-08-10 09:03 am |
IO Biotech Inc. | IOBT | Vivo Capital IX LLC Vivo Capital Fund IX L.P. Vivo Opportunity LLC Vivo Opportunity Fund Holdings L.P. 10% Owner |
3,157,894 | $1.9 | $5,999,999 | 9,331,333 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-04-02 Option Award |
2025-04-04 4:18 pm |
N/A 2035-04-02 |
IO Biotech Inc. | IOBT | Zocca Mai-Britt Chief Executive Officer |
580,000 | $0 | 580,000 (Direct) |
View |
| 2025-04-02 Option Award |
2025-04-04 4:16 pm |
N/A 2035-04-02 |
IO Biotech Inc. | IOBT | Sullivan Amy Chief Financial Officer |
215,000 | $0 | 215,000 (Direct) |
View |
| 2025-04-02 Option Award |
2025-04-04 4:13 pm |
N/A 2035-04-02 |
IO Biotech Inc. | IOBT | Smith Devin Whittemore General Counsel |
140,000 | $0 | 140,000 (Direct) |
View |
| 2025-04-02 Option Award |
2025-04-04 4:12 pm |
N/A 2035-04-02 |
IO Biotech Inc. | IOBT | Burkavage Brian Chief Accounting Officer |
65,000 | $0 | 65,000 (Direct) |
View |
| 2025-04-02 Option Award |
2025-04-04 4:09 pm |
N/A 2035-04-02 |
IO Biotech Inc. | IOBT | Ahmad Qasim Iftikhar Chief Medical Officer |
215,000 | $0 | 215,000 (Direct) |
View |
| 2024-06-06 Option Award |
2024-06-07 4:19 pm |
N/A 2034-06-06 |
IO Biotech Inc. | IOBT | Smith David V Director |
45,642 | $0 | 45,642 (Direct) |
View |
| 2024-06-06 Option Award |
2024-06-07 4:18 pm |
N/A 2034-06-06 |
IO Biotech Inc. | IOBT | Hunter Heidi Director |
45,642 | $0 | 45,642 (Direct) |
View |
| 2024-06-06 Option Award |
2024-06-07 4:17 pm |
N/A 2034-06-06 |
IO Biotech Inc. | IOBT | Hirth Peter Director |
45,642 | $0 | 45,642 (Direct) |
View |
| 2024-06-06 Option Award |
2024-06-07 4:16 pm |
N/A 2034-06-06 |
IO Biotech Inc. | IOBT | Glaub Kathleen Sereda Director |
45,642 | $0 | 45,642 (Direct) |
View |
| 2024-06-06 Option Award |
2024-06-07 4:14 pm |
N/A 2034-06-06 |
IO Biotech Inc. | IOBT | Elling Christian E Director |
45,642 | $0 | 45,642 (Direct) |
View |
| 2024-06-06 Option Award |
2024-06-07 4:12 pm |
N/A 2034-06-06 |
IO Biotech Inc. | IOBT | Collins Helen Louise Director |
45,642 | $0 | 45,642 (Direct) |
View |
| 2024-03-15 Option Award |
2024-03-18 4:27 pm |
N/A 2034-03-15 |
IO Biotech Inc. | IOBT | Zocca Mai-Britt Chief Executive Officer |
750,000 | $0 | 750,000 (Direct) |
View |
| 2024-03-15 Option Award |
2024-03-18 4:24 pm |
N/A 2034-03-15 |
IO Biotech Inc. | IOBT | Sullivan Amy Chief Financial Officer |
280,000 | $0 | 280,000 (Direct) |
View |
| 2024-03-15 Option Award |
2024-03-18 4:23 pm |
N/A 2034-03-15 |
IO Biotech Inc. | IOBT | Smith Devin Whittemore General Counsel |
185,000 | $0 | 185,000 (Direct) |
View |
| 2024-03-15 Option Award |
2024-03-18 4:22 pm |
N/A 2034-03-15 |
IO Biotech Inc. | IOBT | Burkavage Brian Chief Accounting Officer |
50,000 | $0 | 50,000 (Direct) |
View |
| 2024-03-15 Option Award |
2024-03-18 4:18 pm |
N/A 2034-03-15 |
IO Biotech Inc. | IOBT | Ahmad Qasim Iftikhar Chief Medical Officer |
280,000 | $0 | 280,000 (Direct) |
View |
| 2023-11-15 Option Award |
2023-11-17 4:47 pm |
N/A 2033-11-15 |
IO Biotech Inc. | IOBT | Collins Helen Louise Director |
64,238 | $0 | 64,238 (Direct) |
View |
Ownership |
2023-08-21 3:40 pm |
N/A N/A |
IO Biotech Inc. | IOBT | Kurma Partners 10% Owner |
0 | $0 | 12,253,230 (Indirect) |
View |
| 2023-08-11 Option Award |
2023-08-15 6:02 pm |
N/A 2033-08-11 |
IO Biotech Inc. | IOBT | Hunter Heidi Director |
64,238 | $0 | 64,238 (Direct) |
View |
| 2023-08-09 Option Award |
2023-08-11 9:24 pm |
2023-08-09 N/A |
IO Biotech Inc. | IOBT | Elling Christian E Director 10% Owner |
7,901,234 | $0.125 | 21,851,920 (Indirect) |
View |
| 2023-08-09 Option Award |
2023-08-11 9:24 pm |
N/A N/A |
IO Biotech Inc. | IOBT | Elling Christian E Director 10% Owner |
7,901,234 | $1.9 | 21,851,920 (Indirect) |
View |
| 2023-08-09 Option Award |
2023-08-11 9:22 pm |
2023-08-09 N/A |
IO Biotech Inc. | IOBT | Lundbeckfond Invest A/S Director 10% Owner |
7,901,234 | $0.125 | 21,851,920 (Direct) |
View |
| 2023-08-09 Option Award |
2023-08-11 9:22 pm |
N/A N/A |
IO Biotech Inc. | IOBT | Lundbeckfond Invest A/S Director 10% Owner |
7,901,234 | $1.9 | 21,851,920 (Direct) |
View |
| 2023-08-09 Option Award |
2023-08-09 8:43 pm |
2023-08-09 N/A |
IO Biotech Inc. | IOBT | Zocca Mai-Britt Chief Executive Officer |
37,037 | $0.125 | 101,008 (Direct) |
View |
| 2023-08-09 Option Award |
2023-08-09 8:43 pm |
N/A N/A |
IO Biotech Inc. | IOBT | Zocca Mai-Britt Chief Executive Officer |
37,037 | $1.9 | 101,008 (Direct) |
View |
| 2023-08-09 Option Award |
2023-08-09 8:41 pm |
2023-08-09 N/A |
IO Biotech Inc. | IOBT | Sullivan Amy Chief Financial Officer |
49,382 | $0.125 | 123,764 (Direct) |
View |
| 2023-08-09 Option Award |
2023-08-09 8:41 pm |
N/A N/A |
IO Biotech Inc. | IOBT | Sullivan Amy Chief Financial Officer |
49,382 | $1.9 | 123,764 (Direct) |
View |
| 2023-08-09 Option Award |
2023-08-09 8:38 pm |
2023-08-09 N/A |
IO Biotech Inc. | IOBT | Smith Devin Whittemore General Counsel |
4,938 | $0.125 | 9,876 (Direct) |
View |
| 2023-08-09 Option Award |
2023-08-09 8:38 pm |
N/A N/A |
IO Biotech Inc. | IOBT | Smith Devin Whittemore General Counsel |
4,938 | $1.9 | 9,876 (Direct) |
View |
| 2023-07-17 Option Award |
2023-07-19 4:20 pm |
N/A 2033-07-17 |
IO Biotech Inc. | IOBT | Ahmad Qasim Iftikhar Chief Medical Officer |
288,153 | $0 | 288,153 (Direct) |
View |
| 2023-06-08 Option Award |
2023-06-13 7:54 pm |
N/A 2033-06-08 |
IO Biotech Inc. | IOBT | Smith David V Director |
41,533 | $0 | 41,533 (Direct) |
View |
| 2023-06-08 Option Award |
2023-06-13 7:54 pm |
N/A 2033-06-08 |
IO Biotech Inc. | IOBT | Nielsen Jack Director |
41,533 | $0 | 41,533 (Direct) |
View |